Trametinib for the treatment of IGHV4-34, MAP2K1-mutant variant hairy cell leukemia.
Andritsos LA, Grieselhuber NR, Anghelina M, Rogers KA, Roychowdhury S, Reeser JW, Timmers CD, Freud AG, Blachly JS, Lucas DM, Lozanski G, Jones JA, Williams K, Oakes C, Jones D, Grever MR.
Andritsos LA, et al. Among authors: freud ag.
Leuk Lymphoma. 2018 Apr;59(4):1008-1011. doi: 10.1080/10428194.2017.1365853. Epub 2017 Sep 18.
Leuk Lymphoma. 2018.
PMID: 28918710
Free PMC article.
No abstract available.